Evidence suggests that certain dietary patterns such as the Mediterranean diet can help to reduce the risk of Alzheimer’s dementia or slow cognitive decline.1 This involves eating a diet rich in fruit, vegetables, whole-grains, legumes, fish, nuts, seeds and healthy fats such as olive oil.
In addition, there are certain specific nutrients (vitamins and minerals) which are important in early Alzheimer’s Disease.
They are:
Fortsyn Connect is the active ingredient in Souvenaid and contains a unique combination of these nutrients. People with Alzheimer’s disease have lower levels of these nutrients, even if they are eating a normal and healthy diet. It is important to maintain good levels of these nutrients to support connections in the brain in early Alzheimer’s disease.
The average adult human brain weighs approximately 1.4kg and is about the size of a medium cauliflower. It contains around 100 billion nerve cells, called neurones, which are connected by 100 trillion connections, known as synapses.
Neurones can be seen as the building blocks of the brain and synapses as the links in the network. Signals are passed through the synapses to allow the brain carry out its many important functions.
In early Alzheimer’s disease, these synapses, or brain connections, begin to decline in number.
The specific nutrients above, which are low in people with Alzheimer’s disease, have an important role in synapses health. It is important to maintain good levels of these nutrients to support connections in the brain in early Alzheimer’s disease.
Souvenaid contains a unique combination of these specific nutrients at levels difficult to achieve from diet alone2. Souvenaid is available as a once a day, 125ml drink in two flavours (strawberry and vanilla). Learn more about Souvenaid here.
You must seek advice from your doctor, specialist nurse, dietitian or pharmacist if you are unsure of your condition or diagnosis or if you would like to use Souvenaid.
Souvenaid is a Food for Special Medical Purposes for the dietary management of early Alzheimer’s disease and must be used under medical supervision.